 |
|
|
|
Fr 20.04.2012 11:40 - 11:50 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 11:40 - 11:55 h
|
analytica 2012 Halle A4, 1.OG, Konferenzraum A41/A42
|
 |
 |
 |
|
|
|
Fr 20.04.2012 11:40 - 12:00 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 11:50 - 12:00 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 11:55 - 12:25 h
|
analytica 2012 Halle A4, 1.OG, Konferenzraum A41/A42
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 12:00 - 12:30 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 12:25 - 12:55 h
|
analytica 2012 Halle A4, 1.OG, Konferenzraum A41/A42
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 12:30 - 13:30 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
|
Markus Hofelich, Redaktionsleiter, Sonderausgabe Biotechnologie des GoingPublic Magazins, Going Public Media AG, München |
|
|
Dr. Axel Polack, General Partner, TVM Capital GmbH, München |
|
|
Michael Motschmann, Vorstand, MIG Verwaltungs AG, München |
|
|
Sven Rohmann, Managing Director Europe, Burrill & Company |
|
|
Karlheinz Schmelig, Geschäftsführer, Creathor Venture Management GmbH, Bad Homburg |
|
|
Prof. Dr. Arne Skerra, Technische Universitaet Muenchen, Lehrstuhl f. Biologische Chemie , Freising-Weihenstephan |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 12:40 - 13:05 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 12:55 - 13:55 h
|
analytica 2012 Halle A4, 1.OG, Konferenzraum A41/A42
|
 |
 |
 |
|
|
|
Fr 20.04.2012 13:05 - 13:25 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 13:25 - 13:45 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 13:30 - 14:00 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 13:45 - 14:15 h
|
analytica 2012 Halle A4, 1.OG, Konferenzraum A41/A42
|
 |
 |
 |
|
|
|
Fr 20.04.2012 14:00 - 15:00 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
|
Dr. Holger Bengs, Geschäftsführender Gesellschafter, BCNP Consultants GmbH, Frankfurt am Main |
|
|
Dr. Holger Zinke, Vorstandsvorsitzender, BRAIN Aktiengesellschaft, Zwingenberg |
|
|
Dr. André Koltermann, Group Vice President Corporate Research and Development, Süd-Chemie AG, München |
|
|
Dr. Thomas Niemann, Clustermanager des Clusters Integrierte Bioindustrie (CIB) Frankfurt, Cluster Integrierte Bioindustrie (CIB) Frankfurt/ HA Hessen Agentur, Wiesbaden |
|
|
Prof. Dr. Christine Lang, CEO, Organobalance GmbH, Berlin |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 14:05 - 14:25 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 14:15 - 16:00 h
|
analytica 2012 Halle A1-A3 und B1,B2
|
 |
 |
 |
|
|
|
Fr 20.04.2012 14:25 - 14:45 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 14:45 - 15:05 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 15:00 - 15:30 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 15:05 - 15:25 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 15:30 - 16:30 h
|
analytica 2012 Forum Biotech, Halle A3
|
 |
| |
|
|
Falko Bozicevic, Chefredakteur, GoingPublic Magazin, GoingPublic Media AG, München |
|
|
Peter Llewellyn-Davies, Mitglied des Vorstands, WILEX AG, München |
|
|
Dr. Martin Schnee, Gründer/ Eigentümer, Schnee Research |
|
|
Jens Holstein, Finanzvorstand, MorphoSys AG, Martinsried |
|
|
Marco Estermann, Head Issuer Relations, SIX Swiss Exchange AG, Zürich |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 15:40 - 16:00 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 16:00 - 16:45 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |
 |
 |
|
|
|
Fr 20.04.2012 16:45 - 17:00 h
|
analytica 2012 Forum Halle B2
|
 |
| |
|
 |